|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000178919 |
Summary for FOXE1 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000178919 | Gene symbol | FOXE1 |
| Gene name | forkhead box E1 | |
| HGNC | 3806 | |
| Entrez ID | 2304 | |
| Gene type | protein_coding | |
| Synonyms | FOXE1|TTF-2|HFKH4 | |
| UniProtAcc | O00358 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for FOXE1 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| FOXE1 | 1.16e+02 | 4.92e+00 | 6.19e-01 | 7.95e+00 | 1.89e-15 | 2.10e-14 | LUAD |
| FOXE1 | 5.07e+03 | 3.24e+00 | 1.10e+00 | 2.95e+00 | 3.16e-03 | 1.54e-02 | ESCA |
| Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for FOXE1 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for FOXE1 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg13827859 | chr9:97852802 | CGI:chr9:97852952-97855228 | promoter | 2.25e-01 | 3.60e-01 | -1.99e+00 | 4.62e-02 | 4.85e-02 | -1.35e-01 |
| BRCA | cg15802898 | chr9:97852919 | CGI:chr9:97852952-97855228 | promoter | 2.27e-01 | 3.86e-01 | -2.01e+00 | 4.46e-02 | 4.79e-02 | -1.59e-01 |
| BRCA | cg19292008 | chr9:97853514 | CGI:chr9:97852952-97855228 | UTR,promoter,exon,gene body | 2.35e-01 | 3.84e-01 | -2.17e+00 | 2.99e-02 | 4.09e-02 | -1.49e-01 |
| BRCA | cg24393316 | chr9:97854187 | CGI:chr9:97852952-97855228 | promoter,exon,CDS,gene body | 3.94e-01 | 6.48e-01 | -2.02e+00 | 4.39e-02 | 4.76e-02 | -2.54e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg24393316 | chr9:97854187 | CGI:chr9:97852952-97855228 | promoter,exon,CDS,gene body | 1.91e-01 | 8.61e-02 | 2.57e+00 | 1.02e-02 | 1.22e-02 | 1.05e-01 |
| LUAD | cg24393316 | chr9:97854187 | CGI:chr9:97852952-97855228 | promoter,exon,CDS,gene body | 2.38e-01 | 5.36e-02 | 3.32e+00 | 8.92e-04 | 1.76e-03 | 1.85e-01 |
| BLCA | cg13791254 | chr9:97854325 | CGI:chr9:97852952-97855228 | promoter,exon,CDS,gene body | 4.14e-01 | 1.31e-01 | 2.35e+00 | 1.88e-02 | 2.33e-02 | 2.83e-01 |
| BLCA | cg15802898 | chr9:97852919 | CGI:chr9:97852952-97855228 | promoter | 2.76e-01 | 8.21e-02 | 2.55e+00 | 1.07e-02 | 1.49e-02 | 1.94e-01 |
| CHOL | cg13564742 | chr9:97852597 | CGI:chr9:97851656-97852340 | promoter | 4.93e-01 | 2.31e-01 | 2.43e+00 | 1.50e-02 | 2.65e-02 | 2.62e-01 |
| CHOL | cg24393316 | chr9:97854187 | CGI:chr9:97852952-97855228 | promoter,exon,CDS,gene body | 8.24e-01 | 1.50e-01 | 3.10e+00 | 1.96e-03 | 1.07e-02 | 6.74e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg13791254 | chr9:97854325 | CGI:chr9:97852952-97855228 | promoter,exon,CDS,gene body | 5.95e-01 | 2.00e-01 | 1.20e+01 | 4.24e-33 | 9.31e-32 | 3.95e-01 |
| BRCA | cg13564742 | chr9:97852597 | CGI:chr9:97851656-97852340 | promoter | 5.20e-01 | 2.15e-01 | 1.28e+01 | 2.75e-37 | 1.21e-35 | 3.05e-01 |
| BRCA | cg13827859 | chr9:97852802 | CGI:chr9:97852952-97855228 | promoter | 2.25e-01 | 7.14e-02 | 1.04e+01 | 3.58e-25 | 3.09e-24 | 1.54e-01 |
| BRCA | cg15802898 | chr9:97852919 | CGI:chr9:97852952-97855228 | promoter | 2.27e-01 | 6.40e-02 | 1.00e+01 | 1.35e-23 | 1.01e-22 | 1.63e-01 |
| BRCA | cg02157015 | chr9:97852962 | CGI:chr9:97852952-97855228 | promoter | 2.12e-01 | 9.26e-02 | 8.28e+00 | 1.25e-16 | 5.15e-16 | 1.19e-01 |
| BRCA | cg19292008 | chr9:97853514 | CGI:chr9:97852952-97855228 | UTR,promoter,exon,gene body | 2.35e-01 | 7.35e-02 | 8.14e+00 | 4.03e-16 | 1.60e-15 | 1.61e-01 |
| BRCA | cg24393316 | chr9:97854187 | CGI:chr9:97852952-97855228 | promoter,exon,CDS,gene body | 3.94e-01 | 6.69e-02 | 4.78e+00 | 1.79e-06 | 3.24e-06 | 3.27e-01 |
| LUAD | cg13827859 | chr9:97852802 | CGI:chr9:97852952-97855228 | promoter | 1.80e-01 | 7.62e-02 | 3.11e+00 | 1.87e-03 | 4.86e-03 | 1.03e-01 |
| LUAD | cg15802898 | chr9:97852919 | CGI:chr9:97852952-97855228 | promoter | 1.66e-01 | 5.75e-02 | 3.02e+00 | 2.54e-03 | 6.00e-03 | 1.09e-01 |
| LIHC | cg13827859 | chr9:97852802 | CGI:chr9:97852952-97855228 | promoter | 2.35e-01 | 9.36e-02 | 2.17e+00 | 3.00e-02 | 3.33e-02 | 1.41e-01 |
| LIHC | cg15802898 | chr9:97852919 | CGI:chr9:97852952-97855228 | promoter | 2.13e-01 | 7.67e-02 | 2.61e+00 | 9.06e-03 | 1.29e-02 | 1.36e-01 |
| LIHC | cg02157015 | chr9:97852962 | CGI:chr9:97852952-97855228 | promoter | 1.98e-01 | 8.08e-02 | 4.01e+00 | 6.11e-05 | 2.65e-04 | 1.17e-01 |
| KIRP | cg13791254 | chr9:97854325 | CGI:chr9:97852952-97855228 | promoter,exon,CDS,gene body | 2.26e-01 | 7.48e-02 | 2.07e+00 | 3.81e-02 | 4.14e-02 | 1.51e-01 |
Top |
Exon skipping events with PSI in TCGA for FOXE1 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for FOXE1 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for FOXE1 |
| TFs related to FOXE1. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| GBM | FERD3L | FOXE1 | 4.47e+00 | 9.81e-01 | 3.44e+00 | 1.19e-02 | Male-biased |
| GBM | NHLH2 | FOXE1 | 4.07e+00 | 9.81e-01 | 2.62e+00 | 3.17e-03 | Male-biased |
| GBM | ZNF141 | FOXE1 | 4.01e+00 | 9.82e-01 | 2.08e+00 | 6.12e-04 | Male-biased |
| GBM | ZNF2 | FOXE1 | 4.20e+00 | 9.85e-01 | 2.72e+00 | 2.89e-03 | Male-biased |
| GBM | ZNF311 | FOXE1 | 4.01e+00 | 9.81e-01 | 2.32e+00 | 1.40e-03 | Male-biased |
| GBM | ZNF335 | FOXE1 | 4.07e+00 | 9.82e-01 | 2.57e+00 | 2.65e-03 | Male-biased |
| GBM | ZNF460 | FOXE1 | 4.09e+00 | 9.81e-01 | 2.67e+00 | 3.46e-03 | Male-biased |
| GBM | ZNF543 | FOXE1 | 4.02e+00 | 9.81e-01 | 2.41e+00 | 1.89e-03 | Male-biased |
| GBM | ZNF566 | FOXE1 | 4.04e+00 | 9.81e-01 | 2.44e+00 | 1.97e-03 | Male-biased |
| GBM | ZNF674 | FOXE1 | 4.13e+00 | 9.82e-01 | 2.80e+00 | 4.58e-03 | Male-biased |
| PAAD | KLF11 | FOXE1 | 3.26e+00 | 6.43e-03 | 4.15e+00 | 9.83e-01 | Female-biased |
| PAAD | KLF5 | FOXE1 | 3.31e+00 | 8.29e-03 | 4.15e+00 | 9.81e-01 | Female-biased |
| PAAD | ZFP64 | FOXE1 | 3.41e+00 | 7.29e-03 | 4.27e+00 | 9.84e-01 | Female-biased |
| PAAD | ZNF180 | FOXE1 | 3.68e+00 | 1.02e-02 | 4.48e+00 | 9.84e-01 | Female-biased |
| PAAD | ZNF304 | FOXE1 | 3.49e+00 | 4.90e-03 | 4.44e+00 | 9.88e-01 | Female-biased |
| PAAD | ZNF311 | FOXE1 | 3.30e+00 | 3.77e-03 | 4.30e+00 | 9.88e-01 | Female-biased |
| PAAD | ZNF383 | FOXE1 | 3.44e+00 | 1.05e-02 | 4.23e+00 | 9.80e-01 | Female-biased |
| PAAD | ZNF44 | FOXE1 | 3.10e+00 | 3.56e-03 | 4.10e+00 | 9.85e-01 | Female-biased |
| PAAD | ZNF460 | FOXE1 | 3.34e+00 | 8.15e-03 | 4.18e+00 | 9.82e-01 | Female-biased |
| PAAD | ZNF543 | FOXE1 | 3.23e+00 | 2.37e-03 | 4.31e+00 | 9.90e-01 | Female-biased |
| PAAD | ZNF566 | FOXE1 | 3.35e+00 | 5.50e-03 | 4.27e+00 | 9.86e-01 | Female-biased |
| PAAD | ZNF611 | FOXE1 | 3.28e+00 | 4.25e-03 | 4.26e+00 | 9.87e-01 | Female-biased |
| PAAD | ZNF792 | FOXE1 | 3.52e+00 | 4.37e-03 | 4.49e+00 | 9.90e-01 | Female-biased |
| THYM | ASCL1 | FOXE1 | 2.86e+00 | 1.16e-03 | 4.07e+00 | 9.84e-01 | Female-biased |
| THYM | FERD3L | FOXE1 | 3.98e+00 | 9.05e-03 | 4.69e+00 | 9.85e-01 | Female-biased |
| THYM | NHLH1 | FOXE1 | 2.97e+00 | 7.10e-04 | 4.31e+00 | 9.89e-01 | Female-biased |
| THYM | NHLH2 | FOXE1 | 3.35e+00 | 1.73e-03 | 4.48e+00 | 9.90e-01 | Female-biased |
| THYM | NR1H4 | FOXE1 | 3.46e+00 | 2.06e-03 | 4.54e+00 | 9.90e-01 | Female-biased |
| THYM | NR1I2 | FOXE1 | 4.14e+00 | 1.28e-02 | 4.77e+00 | 9.82e-01 | Female-biased |
| THYM | PATZ1 | FOXE1 | 3.39e+00 | 1.50e-03 | 4.55e+00 | 9.91e-01 | Female-biased |
| THYM | PRDM1 | FOXE1 | 4.73e+00 | 9.93e-01 | 3.65e+00 | 1.92e-03 | Male-biased |
| THYM | SALL4 | FOXE1 | 3.11e+00 | 3.16e-03 | 4.07e+00 | 9.82e-01 | Female-biased |
| THYM | SOX8 | FOXE1 | 5.18e+00 | 9.94e-01 | 4.23e+00 | 3.26e-03 | Male-biased |
| THYM | TCF12 | FOXE1 | 2.93e+00 | 1.30e-03 | 4.12e+00 | 9.84e-01 | Female-biased |
| THYM | TCF3 | FOXE1 | 2.95e+00 | 1.06e-03 | 4.19e+00 | 9.86e-01 | Female-biased |
| THYM | ZFP64 | FOXE1 | 3.82e+00 | 1.03e-02 | 4.50e+00 | 9.81e-01 | Female-biased |
| THYM | ZNF141 | FOXE1 | 3.49e+00 | 1.78e-03 | 4.61e+00 | 9.91e-01 | Female-biased |
| THYM | ZNF335 | FOXE1 | 3.44e+00 | 4.16e-03 | 4.34e+00 | 9.85e-01 | Female-biased |
| THYM | ZNF37A | FOXE1 | 3.64e+00 | 9.18e-03 | 4.34e+00 | 9.80e-01 | Female-biased |
| THYM | ZNF394 | FOXE1 | 3.41e+00 | 5.23e-03 | 4.26e+00 | 9.83e-01 | Female-biased |
| THYM | ZNF460 | FOXE1 | 3.97e+00 | 1.03e-02 | 4.65e+00 | 9.83e-01 | Female-biased |
| THYM | ZNF479 | FOXE1 | 3.54e+00 | 3.45e-03 | 4.50e+00 | 9.88e-01 | Female-biased |
| THYM | ZNF674 | FOXE1 | 3.69e+00 | 3.66e-03 | 4.63e+00 | 9.90e-01 | Female-biased |
| THYM | ZNF823 | FOXE1 | 4.37e+00 | 9.82e-01 | 3.67e+00 | 8.82e-03 | Male-biased |
| FOXE1 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
 |
Top |
Sex-biased RBP-ES network for FOXE1 |
| RBPs related to ES in FOXE1. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| FOXE1 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs10120856 | chr9:92785243:A:G | - | 0.11223650703458 | 0.0417473013512646 | HNSC | Female-baised eQTL |
| rs10120915 | chr9:92785443:A:C | - | 0.11223650703458 | 0.0417473013512646 | HNSC | Female-baised eQTL |
| rs10121597 | chr9:92787928:G:A | - | 0.11223650703458 | 0.0417473013512646 | HNSC | Female-baised eQTL |
| rs2181585 | chr9:92789548:G:A | - | 0.11223650703458 | 0.0417473013512646 | HNSC | Female-baised eQTL |
| rs6479431 | chr9:92784607:G:A | - | 0.11408278585818 | 0.0450197963587157 | HNSC | Female-baised eQTL |
| rs1022844 | chr9:92791182:A:T | - | 0.111515132528537 | 0.0474701092771427 | HNSC | Female-baised eQTL |
| rs4742989 | chr9:106342621:C:T | - | -0.0834581291460414 | 0.00274346486779857 | LUAD | Female-baised eQTL |
| rs7852451 | chr9:106346724:A:G | - | -0.0834581291460414 | 0.00274346486779857 | LUAD | Female-baised eQTL |
| rs9650727 | chr9:106339105:A:C | - | -0.0833411767554168 | 0.00279400762794326 | LUAD | Female-baised eQTL |
| rs2048100 | chr9:106335908:A:C | - | -0.0797852495068382 | 0.00452699350620117 | LUAD | Female-baised eQTL |
| rs7035003 | chr9:106336561:G:T | - | -0.0797852495068382 | 0.00452699350620117 | LUAD | Female-baised eQTL |
| rs9650726 | chr9:106338699:T:C | - | -0.0797852495068382 | 0.00452699350620117 | LUAD | Female-baised eQTL |
| rs10116613 | chr9:106327308:A:G | - | -0.0788163180099178 | 0.00549172995876803 | LUAD | Female-baised eQTL |
| rs10816381 | chr9:106330462:A:C | - | -0.0788163180099178 | 0.00549172995876803 | LUAD | Female-baised eQTL |
| rs620311 | chr9:90011623:A:C | - | -0.0605705877729423 | 0.00681096672444661 | LUAD | Female-baised eQTL |
| rs1484370 | chr9:106334474:C:T | - | -0.0764647035348467 | 0.0070199316444314 | LUAD | Female-baised eQTL |
| rs57060377 | chr9:90302560:A:G | - | 0.0603793291999805 | 0.0211918987832173 | LUAD | Female-baised eQTL |
| rs12344001 | chr9:90234328:G:A | - | 0.0592540220169319 | 0.0252426810861001 | LUAD | Female-baised eQTL |
| rs10820785 | chr9:105112203:A:C | - | 0.0489941771621914 | 0.0252820374345209 | LUAD | Female-baised eQTL |
| rs73512752 | chr9:102564524:A:G | - | 0.049551118375753 | 0.032806082657747 | LUAD | Female-baised eQTL |
| rs10820862 | chr9:91510448:A:G | - | 0.0612440160195476 | 0.0333965548370317 | LUAD | Female-baised eQTL |
| rs10820864 | chr9:91511906:G:A | - | 0.0612440160195476 | 0.0333965548370317 | LUAD | Female-baised eQTL |
| rs17303618 | chr9:95841196:C:A | - | 0.0588577302276087 | 0.0357088866898596 | LUAD | Female-baised eQTL |
| rs79590813 | chr9:89992800:T:G | - | 0.0485352424596818 | 0.0375427478418102 | LUAD | Female-baised eQTL |
| rs117285410 | chr9:89993601:T:C | - | 0.0485352424596818 | 0.0375427478418102 | LUAD | Female-baised eQTL |
| rs75139152 | chr9:89993840:G:T | - | 0.0484476497016428 | 0.0383704358155093 | LUAD | Female-baised eQTL |
| rs10512262 | chr9:99042726:G:A | - | 0.0423955996307966 | 0.0393706514908299 | LUAD | Female-baised eQTL |
| rs10820863 | chr9:91511621:C:G | - | 0.0589221240114853 | 0.0436994081504422 | LUAD | Female-baised eQTL |
| rs74617655 | chr9:90005326:G:A | - | 0.0473971129169622 | 0.0474764094312906 | LUAD | Female-baised eQTL |
| rs78389330 | chr9:89953115:G:A | - | 0.0436701217766027 | 0.0490733721977964 | LUAD | Female-baised eQTL |
| rs59021050 | chr9:89942978:A:C | - | 0.043577546834434 | 0.0498767770168033 | LUAD | Female-baised eQTL |
| rs77918388 | chr9:89944377:C:G | - | 0.043577546834434 | 0.0498767770168033 | LUAD | Female-baised eQTL |
| rs78530397 | chr9:89944388:A:C | - | 0.043577546834434 | 0.0498767770168033 | LUAD | Female-baised eQTL |
| rs75788647 | chr9:89946853:G:A | - | 0.043577546834434 | 0.0498767770168033 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs16925267 | chr9:106140405:T:C | - | 0.0619369042679268 | 0.00106263262696451 | LUAD | Male-baised eQTL |
| rs62558503 | chr9:90666718:G:C | - | 0.0765656876395683 | 0.00328971533667508 | LUAD | Male-baised eQTL |
| rs79139199 | chr9:90667561:T:C | - | 0.0765656876395683 | 0.00328971533667508 | LUAD | Male-baised eQTL |
| rs7866564 | chr9:106397883:G:T | - | -0.0760914265641112 | 0.00414862280138188 | LUAD | Male-baised eQTL |
| rs12683896 | chr9:94927408:A:G | - | 0.0727878899395006 | 0.00432136356014292 | LUAD | Male-baised eQTL |
| rs1484371 | chr9:106393398:C:G | - | -0.0733683883844932 | 0.00543104260493772 | LUAD | Male-baised eQTL |
| rs139495350 | chr9:102760580:A:C | - | 0.0648373549575398 | 0.00615043740724657 | LUAD | Male-baised eQTL |
| rs12554043 | chr9:94931040:T:C | - | 0.0703551910096994 | 0.00622904101111462 | LUAD | Male-baised eQTL |
| rs67490803 | chr9:94931275:A:G | - | 0.0703551910096994 | 0.00622904101111462 | LUAD | Male-baised eQTL |
| rs12551506 | chr9:94940746:G:A | - | 0.0703551910096994 | 0.00622904101111462 | LUAD | Male-baised eQTL |
| rs2095069 | chr9:94940218:T:C | - | 0.0703016225207835 | 0.0063449361858646 | LUAD | Male-baised eQTL |
| rs56662263 | chr9:106153874:G:A | - | 0.047140136107326 | 0.0121808830939192 | LUAD | Male-baised eQTL |
| rs4742993 | chr9:106396651:C:T | - | -0.0682431652387184 | 0.012609452620423 | LUAD | Male-baised eQTL |
| rs7038938 | chr9:106154614:A:G | - | 0.0464552172295271 | 0.014278739539698 | LUAD | Male-baised eQTL |
| rs7867254 | chr9:96535584:C:G | - | 0.0627082405568354 | 0.0162304714523735 | LUAD | Male-baised eQTL |
| rs6477511 | chr9:106393186:G:A | - | -0.0621688330456163 | 0.0224522496780402 | LUAD | Male-baised eQTL |
| rs71494574 | chr9:105957251:G:A | - | 0.0581387702528343 | 0.0301225563105179 | LUAD | Male-baised eQTL |
| rs7850106 | chr9:105969383:A:T | - | 0.058001947241894 | 0.0309196132146282 | LUAD | Male-baised eQTL |
| rs7858847 | chr9:106144159:T:A | - | 0.0413288881248751 | 0.0343607659796946 | LUAD | Male-baised eQTL |
| rs7860539 | chr9:105327038:A:G | - | 0.0616314133659169 | 0.0498951874586617 | LUAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000178919 |
| CpG Site: cg13696609 | |
| Position to Gene: gene,exon,enhancer,UTR | |
| Male Effect: - | |
| Female Effect: -0.150540545103232 |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg13696609 | chr9:97855428 | gene,exon,enhancer,UTR | -0.150540545103232 | 7.81414950798157e-06 | -0.3460944781459052 | 1.3795370661266369e-08 | LUAD |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of FOXE1 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000178919 | FOXE1 | C1855794 | Bamforth syndrome | 1 | CTD_human |
| ENSG00000178919 | FOXE1 | C1968699 | Hypothyroidism, Thyroidal, With Spiky Hair And Cleft Palate | 1 | CTD_human |
| ENSG00000178919 | FOXE1 | C4225293 | THYROID CANCER, NONMEDULLARY, 4 | 1 | CTD_human |
